How to Value a Hearing Aid and Audiology Practice

Audiology is at an inflection point that makes valuation more complex than it's been in decades. The FDA's 2022 ruling allowing over-the-counter hearing aid sales opened the door for Apple, Sony, Jabra, and dozens of startups to sell devices directly to consumers at $200-$800 per pair. Meanwhile, traditional audiologists are selling premium devices at $4,000-$6,000 per pair and wondering what their practices are worth in this new landscape.

Having valued audiology practices before and after the OTC ruling, I can tell you: the disruption is real but narrower than the headlines suggest. The practices that are thriving — and commanding premium valuations — have adapted their business model in specific ways that I'll walk through.

The Baseline Valuation Framework

Audiology practices are valued using two primary methods:

• Percentage of gross revenue: 50-75% of annual revenue. This is the most commonly used method for solo and small group practices. A practice generating $1.5M in revenue would sell for $750K-$1.13M.
• SDE multiple: 3-6x SDE. More accurate for practices where the owner's compensation is clear. A solo audiologist with $800K revenue and $280K SDE would sell for $840K-$1.68M.

For larger multi-location practices with $3M+ revenue and professional management, EBITDA multiples of 5-8x apply, and the buyer pool shifts to include PE-backed hearing care platforms and manufacturer-owned retail networks.

The wide range (50-75% of revenue, 3-6x SDE) reflects the fact that audiology practices vary enormously in profitability depending on their pricing model, product mix, and service revenue. Let me explain why.

Bundled vs. Unbundled Pricing: The Margin Story

This is the single most important economic distinction in audiology practice valuation, and most practice owners don't fully appreciate how it affects what their business is worth.

Bundled pricing (the traditional model): the patient pays one price — say $5,000 for a pair of hearing aids — that includes the devices, fitting, programming, all follow-up visits, and often 2-3 years of adjustments and cleanings. Revenue is front-loaded but ongoing service obligations reduce effective margins. A practice doing $1.2M in bundled revenue might have $400K in device cost (COGS), $200K in pre-paid service obligations, and $600K gross profit — roughly 50% gross margin.

Unbundled pricing (the emerging model): the patient pays separately for the device ($2,500-$3,500 per pair at wholesale-plus markup), fitting and programming ($400-$800), and ongoing service visits ($75-$150 each). Revenue is more distributed over time, service revenue is recognized when delivered, and margins on each component are transparent. A practice doing $1.2M in unbundled revenue might show 55-65% gross margin because service revenue is accounted for when earned.

Why does this matter for valuation? Buyers — especially sophisticated ones — look at the unbundled economics to understand what the practice actually earns. A bundled practice at $1.2M revenue might have the same true profitability as an unbundled practice at $900K because the bundled model hides deferred service costs. Practices that have transitioned to unbundled pricing typically show cleaner margins and get higher valuation multiples as a result.

The OTC Hearing Aid Impact: Narrower Than You Think

The OTC hearing aid category (devices sold without professional fitting for perceived mild-to-moderate hearing loss) has captured roughly 5-8% of the hearing aid unit market since the FDA ruling. That's meaningful but not the existential threat many predicted.

Here's why the impact on practice valuations has been moderate:

OTC captures entry-level, not premium.The typical OTC buyer is a first-time user with mild loss who would have otherwise purchased entry-level devices at $1,500-$2,500 per pair. These were always the lowest-margin sales for audiologists. The premium segment — patients with moderate-to-severe loss needing custom fitting, real-ear measurement, and ongoing programming — isn't served by OTC devices. Practices that were already focused on complex cases and premium fittings have seen minimal revenue impact.

The service relationship still matters.A Costco hearing aid (which was the pre-OTC "disruption" and remains a larger competitive threat than OTC) costs $1,400-$1,800 per pair. But Costco can't provide the diagnostic audiology, vestibular testing, tinnitus management, or ongoing aural rehabilitation that a full-service audiology practice offers. Practices that have built their identity around comprehensive hearing healthcare — not just device sales — are retaining patients at high rates.

The data supports resilience. Average hearing aid selling prices at private practices have actually increased since the OTC ruling — from roughly $2,300 per unit in 2022 to $2,500-$2,800 per unit in 2025. What happened is that practices traded volume at the low end for higher average selling prices at the premium end, and total revenue per practice has remained stable or grown.

Key Valuation Metrics

Hearing aid units dispensed per month. The benchmark is 15-25 units per audiologist per month. Below 12 suggests weak patient flow or conversion issues. Above 25, and the audiologist is either highly efficient or possibly rushing fittings (which affects long-term patient satisfaction and return rates).

Average selling price per unit. Currently $2,000-$3,000 per unit for private practices, or $4,000-$6,000 per pair. Practices consistently selling above $2,500 per unit are positioned in the premium segment and less vulnerable to OTC and Costco competition. The ASP directly drives revenue per patient and is the first metric I look at.

Service plan attachment rate. What percentage of hearing aid patients purchase an extended service plan ($300-$600 per year) after their initial bundled period expires? Top practices achieve 60-70% attachment rates, generating $200K-$400K in annual recurring service revenue. This revenue stream is highly valued by acquirers because it's predictable and high-margin.

Patient demographics and database size. The aging population tailwind is real — the 65+ population is growing at 3% annually, and roughly 28% of adults 65+ have hearing loss that could benefit from amplification. A practice with 3,000+ active patients (seen within 3 years) in a market with strong 65+ demographics has a built-in growth trajectory that buyers will pay for.

Audiologist count and credentials. Practices with multiple audiologists (Au.D.) are valued significantly higher than solo practices. Each audiologist generates $350K-$600K in annual revenue. Audiologists with specialty credentials in cochlear implants, vestibular disorders, or pediatric audiology add service lines that diversify revenue beyond hearing aids.

The Manufacturer Relationship Factor

Unlike most healthcare practices, audiology valuations are meaningfully affected by manufacturer relationships. The "Big Five" hearing aid manufacturers — Sonova (Phonak, Unitron), Demant (Oticon, Bernafon), WS Audiology (Widex, Signia), GN (ReSound, Jabra), and Starkey — all have preferred provider programs that affect device pricing, marketing support, and patient referrals.

Sonova operates the largest manufacturer-owned hearing care retail network globally (Audika, Connect Hearing, and various regional brands), with 3,500+ clinics. They actively acquire independent practices, typically paying 60-75% of revenue. Demant owns Audika and HearingLife (1,600+ US locations). WS Audiology owns HearUSA. These manufacturer networks are among the most active acquirers of audiology practices.

If a manufacturer-owned network acquires your practice, the deal structure typically includes: purchase price at 55-75% of trailing revenue, a 2-3 year employment agreement for the selling audiologist, conversion to the manufacturer's product line (which may affect margins if you were multi-brand), and integration into their marketing and operational systems. The prices are generally at the lower end of market range, but the process is streamlined and closings are fast.

Who Else Is Buying

Beyond manufacturer networks, the buyer landscape includes:

• ENT physician groups: Adding audiology as an ancillary service line. They pay 3-5x SDE and value the referral synergy — patients diagnosed with hearing loss by the ENT are sent down the hall for fitting.
• PE-backed hearing care platforms: Several PE firms have entered hearing care, building multi-location platforms. These pay 5-8x EBITDA for practices with $2M+ revenue and multiple audiologists.
• Individual audiologists: Younger audiologists buying their first practice, typically using SBA loans. They pay 50-65% of revenue or 3-4x SDE — the lower end of the range but often the fastest path to a clean exit.
• Retail optical chains: Companies like MyEyeDr. (which has explored hearing services) see audiology as a natural adjacency to optometry. This is an emerging buyer category.

Preparing Your Audiology Practice for Sale

Transition to unbundled pricing.If you're still selling fully bundled, start transitioning now. It takes 12-18 months for the financials to fully reflect unbundled economics, and the cleaner margin picture will support a higher multiple.

Build your service revenue. Service plans, diagnostic audiology (tympanometry, ABR, OAE), tinnitus management programs, and hearing conservation services all diversify revenue beyond device sales. Practices where hearing aids represent less than 70% of total revenue are valued more highly than those at 85%+ because the revenue base is more diversified and less susceptible to device pricing pressure.

Grow your patient database.The most valuable asset in an audiology practice is the patient list — specifically patients with diagnosed hearing loss who are candidates for devices. Every patient in your database who hasn't yet purchased hearing aids represents future device revenue of $4,000-$6,000. A database of 5,000 patients with 40% unconverted represents $8M-$12M in lifetime device revenue opportunity. Buyers understand this math.

Add an audiologist. Solo practices are structurally limited in what buyers will pay. Adding a second audiologist — even part-time, 3 days per week — reduces owner dependency, increases capacity, and signals to buyers that the practice can operate independently of the selling owner.

The Bottom Line

Audiology practice valuation in 2026 is shaped by the OTC disruption, the bundled-to-unbundled pricing transition, and an aging population that guarantees growing demand. Practices valued at the top of the range (70-75% of revenue, 5-6x SDE) have adapted: they've moved to unbundled pricing, built service revenue streams, focused on premium fittings that OTC can't replicate, and developed patient databases that represent years of future device revenue. The acquirer landscape is active — from manufacturer networks to PE platforms to ENT groups — so the question isn't whether there's a buyer for your practice, but which buyer will value your specific strengths most highly.